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(57) ABSTRACT 
Disclosed is a method and the resulting product thereof 
comprising a solid light-conducting fiber with a point of 
attachment and having a textured surface site consisting a 
textured distal end prepared by being placed in a vacuum 
and then subjected to directed hyperthermal beams compris- 
ing oxygen ions or atoms. The textured distal end comprises 
cones or pillars that are spaced upon from each other by less 
than 1 micron and are extremely suitable to prevent cellular 
components of blood from entering the valleys between the 
cones or pillars so as to effectively separate the cellular 
components in the blood from interfering with optical sens- 
ing of the glucose concentration for diabetic patients. 
5 Claims, 6 Drawing Sheets 
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ENERGETIC ATOMIC AM) IONIC OXYGEN responsive needed to be deposited to perform the glucose 
TEXTURED OPTICAL SURFACES FOR determination. Increased surface area allows one to utilize a 
BLOOD GLUCOSE MONITORING small blood droplet, for instance, a droplet having a volume 
of one (1) to five (5) microliters, or preferably 1 to 2.5 
CROSS-REFERENCE TO RELATED 5 microliters. The '937 patent allows for a reduction relative 
APPLICATIONS to the prior art thereof, of about one-fifth to about one-tenth 
of the fluid volume necessary blood glucose sensing. It is 
This application is a continuation-in-part of parent appli- desired that further improvements to the surface area be 
cation Scr. No. 101942.637 filed Sep. 16, 2004 now aban- provided, so as to correspondingly reduce the amount of 
doned. l o  blood necessary for determination of glucose for diabetics. 
The '937 patent provides a textured surface using various 
ORIGIN OF THE INVENTION means, such as ion beam sputtering, plasma etching includ- 
ing atomic oxygen plasma, physical abrasion, chemical 
The invcntion dcscnbcd hcrcin was made by an employee etching, sputtering or ablation by high energy beams, or 
of the Unitcd Statcs Govcrnmcnt and may be used by or for is deposition of dendritic-like structures thereon. The textured 
the Govcrnmcnt for povcmmcntal purposes without pay- surface of the '937 patent is intended to provide a means for 
ment of any royaltics thcrcon or thcrcfor. separating cellular components in blood from the plasma of 
the blood so as to allow optical sensing of the glucose 
FIELD OF THE INVENTION concentration in the blood. The processes described in the 
zo '937 patent for developing the textured surface need to 
The prcscnt invcntion rclates to a scnsing device for produce a cone or pillar structure at the ends of optical fibers 
determination of compounds in fluids, and more particularly, or other sensing surfaces which are sufficiently close-so as 
to a solid light-conducting fiber comprising the sensing to prevent the cellular components from entering the micro- 
device with a point of attachment and having a textured scopic valleys between the cones or pillars so that optical 
surface consisting of a distal end prepared by being placed 25 sensing of the glucose concentration can be performed. Also, 
in a vacuum systcm and thcn subjcctcd to directed hypoth- it is desired to have a sufficiently high aspect ratio (height to 
ermal bcams comprising oxygcn ions or atoms. width) of cones or pillars to allow sufficient surface area for 
optical determination of the glucose concentration in the 
BACKGROUND OF THE INVENTION blood. 
30 In pursuit for finding desired pillar structures for the 
The quantification of chemical and biochemical compo- textured surfaces, some of the different processes mentioned 
nents in aqucous fluids, and particularly in biological fluids in the '937 patent were investigated and may be further 
such as wholc blood or urine and in biological fluid deriva- described with reference to FIG. 1 herein, which illustrates 
tives such as serum and plasma, is of ever increasing a Scanning Electron Microscope image of the end of a 
irnportancc. Important applications exist in medical diagno- 35 polymethylmethacrylate optical fiber that was textured by 
sis and trcatmcnt and in thc quantification of exposure to the use of thermal energy ( 4 . 5  eV) atomic oxygen through 
therapeutic drugs, intoxicants, hazardous chemicals and the salt dust for enhancing texturing. 
like. These applications include the detection and quantifi- The disadvantages of prior art results shown in FIG. 1 is 
cation of an increasing variety of certain circulating anti- that the craters produced were too wide to prevent cellular 
bodies, cancer-related metabolites, genetically derived 40 blood components from entering the optical sensing areas 
chemical traccrs, and hormones emitted during events such and the aspect ratio (height to width) of the surface features 
as pregnancy. In many instances, the amounts of materials does not offer high gains in surface area relative to flat 
being detcrmined are minuscule in the range of a microgram surfaces. As can be seen in FIG. 1, the cone or crater ridges 
or less per deciliter. are approximately 20-30 microns apart far too much to 
One common medical test is the measurement of blood 45 achieve their desired goals. More particularly, the spacing 
glucose levels by diabetics which is more fully described in between cones or ridges needs to be S 5  microns to block the 
U.S. Pat. No. 5,859,937 ('937) of H. Nomura and herein entry of blood cells into the cone valleys. Thus, the craters 
incorporated by reference. Portions of the teachings of the did not provide separation of the plasma from the blood in 
'937 patent are used herein for the sake of completeness. The the areas of the valleys between the cones or pillars where 
glucose determination, as described in the '937 patent, 50 optical sensing of the glucose concentration needs to occur. 
typically entails the diabetic piercing the skin of his or her Use of thermal energy ( ~ 0 . 5  eV) atomic oxygen, sometimes 
finger with a lance, followed by squeezing or expression of referred to as isotropic thermal energy, to texture the sur- 
a blood droplet. The blood droplet is then transferred to a faces of clear polymers such as polymethylmethacrylate, 
reagent pad or test strip. The amount of blood that is polystyrene or other hydrocarbon polymer (even with the 
conveniently expressed from a finger prick is governed by 55 use of small particle salt shielding) causes wide almost 
the size and depth of penetration of the lance. Too small a hemispherical craters to form surface features which are 
nick results in an inadequately sized blood sample for the only as high as they are wide. The aspect ratio of only 
intended analysis. Conversely, too deep a nick results in an approximately one (1) requires greater volume blood 
oversized blood sample. Pain is experienced in the lancing samples than desirable. It is desired that textured surfaces for 
procedure, and the degree of pain is associated with the size 60 optical sensors used for blood testing be provided that 
and depth of penetration of the lance. provide cones or pillars that are spaced apart from each other 
The teachings of the '937 patent provides a textured site by less than 5 microns, preferably about 1 micron, and 
allowing for an increased surface area, compared to other having an aspect ratio (height to width) of greater than one 
prior art devices, for use in blood sampling. The increased (1). 
surface area provides an advantage relating to minimizing 65 Another process related to optical fibers is disclosed in 
the invasive feature of glucose testing because the surface U.S. Pat. No. 6,200,737Bl ('737B1) of Walt et al that 
area being very small, greatly reduces the level of analyte- employs photolithograph. The cost of using photolithogra- 
US 7,305,154 B1 
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phy on the ends of multiple bundle fibers is exceedingly high by the use of thermal energy (<0.5 eV) atomic oxygen 
for blood glucose monitoring because it is extremely diffi- through salt dust to enhance texturing; 
cult to simply stack a half million of the multiple bundle FIG. 2 is a prior art schematic view of fibers with textured 
fibers together to be used for blood glucose monitoring and surface sites; 
perfom ~hotoli thogra~h~ t ereon as disclosed in the 5 FIG. 3 is a prior art schematic viei of a cone field within 
'737B1 patent. More particularly, because of the small size a textured surface of an optic fiber; 
and the requirement that only short (1-2 cm) lengths need to FIG. 4 is a prior art cross-section of a cone field with the be used for blood glucose monitoring, it would require the deposited along adjacent erythrocyte; 
half million stacking. This stacking can be simplified how- FIG. is a block diagTam of a process that provides 
ever, as the practice of the present inven- lo hypothermal ionic or atomic oxygen texturing of optical tion, by using large single fibers where no individual surface surfaces; 
treatment need be the cost of the 
mG. 6 is an e&ged view of the cones or pillars of the process of the '737 patent to place surface texture on the 
associated fibers is unnecessarily and disadvantageously textured surfaces provided by the embodiment of FIG. 5; 
high. FIG. 7 is a block diagram of the apparatus that provides 
1s the desired process of the present invention; and 
OBJECTS OF THE INVENTION FIG. 8 is a Scanning Electron Microscope image of an 
atomic oxygen textured optical fiber of the present invention 
is a primary object of the present invention to provide that was textured by means of End Hall atomic or ionic 
a process that creates a sensor having a textured surface Oxygen sources which produced eV) 
comprising cones or pillars that are spaced apart from each 20 atomic Oxygen ions- 
other by less than 5 microns, preferably about 1 micron, and 
having an aspect ratio of greater than one (1). DETAILED DESCRIPTION OF THE 
Moreover. it is an obiect of the uresent invention to PREFERRED EMBODIMENTS 
provide a process for m a h g  fine texkre, high aspect ratio 
cone surface at the distal end of a solid light-conducting fiber 25 One of the purposes of the present invention is to create 
that is necessary for optical fiber blood glucose monitoring a surface on optically transparent polymers which has 
with small blood samples. closely spaced cones or pillars so as to prevent blood cellular 
It is a further object of the present invention to provide for components during optical monitoring from entering the 
an optical sensor having cones or pillars that are sufficiently valleys between the cones or pillars, which would otherwise 
close so as to prevent cellular blood components for inter- 30 interfere with the optical sensing of blood glucose concen- 
fering with optical sensing of the blood glucose concentra- tration. It is also a purpose of the present invention to 
tion. produce a high surface area of high aspect-ratio cones or 
Still further, it is an object of the present invention to p a a s  which are taller than they are wide so as to enable 
provide a process that creates a textured surface for an glucose sensing with a minbnum volume of blood- The 
optical sensing device which has a high surface area that 35 cellular components in blood predominantly consist of red 
correspondingly allows for a reduction in the amount of blood cells (erythrocytes of 6.6-7.5 microns diameter) and 
blood needed to be removed from a patient so as to reduce white blood cells Oeukoc~tes such l ~ m ~ h o c ~ t e s  of 8-10 
the pain to which the patient needs to be subjected for microns diameter, neutrophils of 12-15 microns diameter, 
glucose determination. eosinophils of 12-15 microns diameter, basophils of 9-10 
It is a further object of the present invention to provide for microns diameter and monocYtes of microns 
optical polymer devices serving the sensors that may be used '' eter). Thus, a 5 micron average spacing between cones or 
for blood plasma diagnostics that require economic separa- pillars would serve to prevent the cellular components of 
tion of plasma in the whole blood for optical sensing blood from entering the valleys between the cones and 
measurements. pillars which needs to be occupied by the plasma only so as 
Further still, it is an object to provide optical fibers used to prevent optical obstruction of the glucose sensing by light for blood glucose monitoring without suffering the draw- 45 emitted from the sides of the cones on the textured optical 
backs of photolithographical processes. fiber end in a manner to be described hereinafter. A further 
enhancement is provided by having the spacing between Ln addition, it is an object of the present invention to cones or pillars be about micron. A high aspect ratio of the provide optical fibers having diameters as to be suffi- texture (cone height to cone separation) provides a greater 
cientl~ to be used for glucose area, thus enabling a smaller volume blood needed 
monitoring. to measure glucose concentration. 
SUMMARY OF THE INVENTION 
The present invention provides for a process that produces 
a solid light-conducting fiber with a point of attachment and 
having a distal end possessing a fine texture, high aspect 
ratio cone surface that provides for optical fiber blood 
glucose monitoring with small blood samples. 
The textured distal end of the solid light-conducting fiber 
is prepared by being placed in a vacuum and then subjected 
to direct hyperthermal beams comprising oxygen ions or 
Another purpose of the present invention is to provide 
optically transparent polymer fibers that can be successfully 
utilized for blood sampling. The previously mentioned 
'737B1 patent disadvantageously comprises a bundle of 
multiple fibers whose overall diameter could range from 1 to 
50 microns in diameter, which is far too small to be practical 
for blood sampling. More particularly, the fibers need to be 
able to be held in individual fingers so as to be inserted into 
a readout device, to be further described hereinafter, after 
touching to a small spot of blood. Even the largest bundle of 
50 microns disclosed in the '737B1 Datent is smaller in 
atoms. diameter than an average human hair: Thus. use of such 
fibers disclosed in the 5 3 7 ~ 1  patent would'cause one to 
BRIEF DESCRIPTION OF THE DRAWINGS easilv break them as well as uotentiallv breaking them off 
65 (po&ntially into your skin) when trying to pick Gp a blood 
FIG. 1 illustrates a prior art Scanning Electron Micro- sample on your body. The present invention provides optical 
scope image of the end of an optical fiber that was textured fibers that do not suffer the drawbacks of prior art devices. 
A still further purpose of the present invention is to 
provide optically transparent polymer fibers having a desired 
shape so as to be utilized for blood sampling. The shape of 
the fibers of '737B1 patent is approximately hemispherical 
and the fibers are very rounded at their distal ends. This 5 
shape is not useful for optical fibers that monitor glucose 
level. The reason for this undesired shape is that the purpose 
of the texture on the end of the fibers is to hold the cellular 
components of the blood from being in contact with the 
glucose sensing sides of the cones that are interrogated by 10 
light beams. However, hemispheres allow a large area of 
contact between the blood cells and the surfaces of the 
hemispheres. This large contact area may cause a misinter- 
pretation of the glucose level in the blood because of the 
light interacting with the blood cells that lie on the surface. 15 
As will be further described hereinafter, the present inven- 
tion provides optical fibers having conical surface structures 
wherein negligible light reaches the very tip of the cones and 
such interactions have little impact because of the micro- 
scopic contact area The invention may be further described 20 
with reference to prior art shown in FIG. 2. 
FIG. 2 illustrates two solid light-conducting fibers 10, and 
12 each being transparent, each having a point of attachment 
14, and each preferably comprised of a polymer material, 
except for silicone. Each of the fibers 10, and 12 has a 2s 
textured surface 16 at the distal end thereof that is provided 
cone field is large, such that it can typically make no more 
than incidental contact with the outermost projections of the 
cones 28. In a determination of a small analyte, such as 
glucose, the reagent deposit 38 within the cone field 30 is 
readily accessed by the analyte, but protected from the 
erythrocytes 40 based on size selection by the cone field 30 
pattern. Changes in the reagent deposit 38, such as by 
development of a colored complex through reaction with an 
analyte, is advantageously detected by means of a light beam 
(indicated by the arrow 18) being transmitted through the 
matrix of the fiber. The textured surface 16 is generally in the 
form of conical or ridge-like structure microns high and 
wide having a desired aspect ratio (lengtwwide) which is 
preferably greater than one (1). The term "cone field" is 
herein defined to include textures, which are not necessarily 
in the specific shape of cones, but may include various 
linear, box-like or angular arrays of projections so long as 
their aspect ratio is greater than one (1). 
The analytic-responsive reagent 38 placed between the 
crevices of the cones or pillars 28 may be one of many 
analyte-sensing systems. In a manner known in the art, for 
blood glucose determinations, the analyte-sensing system is 
preferably a composition including a peroxidase enzyme and 
color-generating chemical couplers. Many combinations of 
such chemical systems for blood glucose determinations are 
disclosed and described in U.S. Pat. No. 4,935,346, which is 
by one of the processes of the present invention to be further herein incorporated by reference. For antigens, antibodies, 
described hereinafter with reference to FIG. 5-8. enzymes, enzyme inhibitors, and various other biochemical 
In one application, at least one end, that is point of agents, attachment of &nity ligands to the textured surface 
attachment 14, of the light-conductive fibers 10 or 12, is 30 16 may be practiced. Herein, the light traveling through the 
placed adjacent to a light source (not shown) for sending a fiber is atfected by the development of resulting affinity 
beam of light 18 down the fiber length. The point of complexes on the textured fiber surface 16. Alternatively, 
attachment 14 of each of the fibers 10 and 12 is also located chemiluminescent or fluorescent techniques may be utilized 
adjacent to a device for measuring light beam characteristics to highlight the a n i t y  attachment of specific biomolecules 
of light 20 or 22 emanating from the fibers 10 or 12, 35 on the textured surface, aportion of the chemiluminescent or 
respectively after being reflected by the distal end 16. For fluorescent light being captured and transmitted through the 
fiber 12, a device 24 may be employed to intercept the fiber to a detector. Attachment of ligands to polymeric 
returning light beam 22 and reflect the light beam 22 surfaces through covalent binding is well known in the art of 
downward, as shown in FIG. 2. When the point of attach- a£Enity membranes. 
ment 14 is to be adjacent to both the light source and the 40 In a preferred method of use of the invention, a light- 
device for measuring the light beam characteristics, light conducting fiber, such as 10 of J3G. 2, having a textured site 
measurement is dependent upon reflection of the light beam, 16 thereon is located at attachment point 14 adjacent to a 
such as light beam 22, by device 24 as shown for fiber 14. light source for transmittal of a light beam 18 into the fiber 
The textured surface 16 may be treated so as to contain an 10, and adjacent also to a device for analysis of light beam 
analyte responsive reagent (not shown in FIG. 1). A chemi- 45 characteristics of light beam 20 emanating from an opposite 
luminescent or fluorescent reaction at the textured site 16 end of the fiber 10 after it is reflected by the textured site 16. 
resulting from reagent-analyte interactions can be advanta- In a most preferred embodiment, both light input and 
geously utilized wherein a portion of the chemiluminescent emanation thereof are at one end of a fiber 10 of predeter- 
or fluorescent light enters the fiber 10 or 12, and is trans- mined length, and the textured site 16 is at an opposite end 
mitted to a device such as a luminometer, located at one end 50 of the fiber 16. The textured surface site 16 is first impreg- 
of the fiber 10, or 12, for detection and quantitation. The nated with an analyte responsive reagent, such as a plasma 
textured surfaces 16 may be further described with reference coated analyte. The textured site 16, is then wetted with a 
to prior art shown in FIG. 3. fluid, such as by contacting the fiber at this site 16 with a 
FIG. 3 provides an enlarged view of a cutaway section of small droplet of blood. Interaction of the reagent with the 
a fiber 10 having a textured surface 16. The textured surface 55 analyte, if any, present in the fluid is allowed to occur, 
16 is schematically depicted in this case as an array of resulting in an observable physical or chemical change at the 
cone-shaped projections or pillars 28 defining a cone field textured site 16. Light passing through the fiber 10 in the 
30, which has been formed within the surface 32 of a fiber region of the textured site 16 is altered in its characteristics 
by removal of portions of surface 32 and subsurface 34 such as frequency and amplitude, one or more of these 
material. Further details of the textured surface 16 may be 60 changes being detectable and preferably quantifiable by the 
further described with reference to prior art in FIG. 4. device utilized for analysis of light beam 20 emanating from 
FIG. 4 shows a representative cross-section 36 of the cone the fiber. More particularly, light intercepting the textured 
field 30, wherein a deposit 38 of the analyte-responsive surface 16 creates a change in the spectral reflectance as a 
reagent has been conventionally placed within the crevices result of the light interacting with the plasma-coated analyte 
between cone projections 28. Also shown in mG. 4 is a 65 surface 16. 
representation of an erythrocyte 40 (a red blood cell), whose In a preferred method of use of the invention, a light- 
size in relationship to the openings between the cones of the conducting fiber, such as 10 of FIG. 2, having a textured site 
7 8 
16 thereon is located at attachment point 14 adjacent to a site 16 by the minimally sized blood droplet. The minimally 
light source for transmittal of a light beam 18 into the fiber sized droplet is to be further described hereinafter. The 
10, and adjacent also to a device for analysis of light beam preparation of the textured surface 16 is of particular impor- 
characteristics of light beam 20 emanating from an opposite tance to the present invention and may be further described 
end of the fiber 10 after it is reflected by the textured site 16. 5 with reference to FIGS. 5-8. 
In a most preferred embodiment, both light input and One of the main contributions of the present invention is 
emanation thereof are at one end of a fiber 10 of predeter- to provide ability to the art to make pillars and cones 28 
mined length, and the textured site 16 is at an opposite end much closer together than any prior art has been able to 
of the fiber 10. The textured surface site 16 is Erst impreg- demonstrate. Alto, the present invention provides for the use 
nated with an analyte responsive reagent, such as a plasma- 10 of directed hyperthermal beams comprised of oxygen atoms 
coated analyte. The textured site 16, is then wetted with a or ions to make the aspect ratio high, which gives the art of 
fluid, such as by contacting the fiber at this site with a small measuring fluid samples a much greater effective surface 
droplet of blood. Interaction of the reagent with the analyte, area relative to prior art techniques, in the form of the 
if any, present in thc fluid is allowed to occur, resulting in an textured surface 16 to receive the fluid samples. 
observable physical or chemical change at the textured site 15 In general, the arrangements shown in FIGS. 5 and 7 
16. Light passing through the fiber 10 in the region of the provide one or more processes used to produce closely- 
textured site 16 is altered in its characteristics such as spaced high aspect-ratio cones or pillars 28, as shown in 
frequency and amplitude, one or more of these changes FIG. 8, to be further described hereinafter, in optically clear 
being detectable and preferably quantifiable by the device polymers consisting of exposing the surfaces of the poly- 
utilized for analysis of light beam 20 emanating from the 20 mers to be textured to a directed beam of energetic atomic 
fiber. More particularly, light intercepting the textured sur- oxygen atoms or ions. The energy of the atomic oxygen 
face 16 creates a change in the specual reflectance as aresult atoms or ions should be hyperthermal (>1 eV) so as to 
of the light interacting with the plasma-coated analyte produce the textured surfaces shown in FIG. 8, rather than 
surface 16. isotropic thermal energy (<0.5 eV), selected by prior art 
As previously mentioned, the diameter of the optical 25 methods, that disadvantageously cause directed atomic oxy- 
fibers 10 and 12 is important to the practice of the present gen reaction with hydrocarbon atoms that make up the 
invention, and it is preferred to be in the range of about 1.0 polymer of the fiber and disadvantageously produce the 
rnm to about 2.0 mm. This diameter provides a fiber 10 or prior art surfaces shown in FIG. 1. 
12 that is able to be held in the fingers of an individual, so In the practice of the present invention, it was determined 
as to be placed in the line of sight of the device utilizing the 30 that the energy level desired was greater than 1 eV. It was 
light beam 20 after the textured surface 16 touches a small further determined that the preferred range was energies in 
spot of blood. Without the benefits of the present invention, the range of 50 to 100 eV. So although it is desired to use 
the usage of prior art fibers having typical diameters from 1 energy levels of greater than 1 eV, the typical range of 
to 50 microns corresponding to the diameter of an average energies used to actually do the texturing, which work best 
human hair may very likely cause the easy breakage of the 35 in terms of high length-to-width cones 28, is in the 50 eV to 
prior art fibcr in use, as well as potentially breaking the fibers 100 eV range. 
off (possibly into the skin) when trying to pick-up a blood The reactions, provided by the present invention, produce 
sample from the individual for blood glucose monitoring. closely-spaced high aspect-ratio cones or pillars. To perform 
As also previously mentioned, the shape of cones of the this process one must place the optical polymers to be 
textured surface 16 of the fibers 10 and 12 that come into 40 textured in a vacuum system, which evacuated to I l ~ l o - ~  
contact with the blood being sampled is important to the tom. Without the vacuum system atomic and ionic oxygen 
practice of the present invention and is preferably conical. may be attenuated such as that which occurs at high pressure 
The reason for the desired conical shape is that the purpose such as air pressure. An energetic (>1 eV) beam of atomic 
of the texture, such as textured surface 16, on the end of the oxygen atoms or ions is then formed in the vacuum system 
fibers, such as 10 and 12, is to hold the cellular components 45 by ion or atom beam accelerating devices, such as End Hall 
of the blood from coming in contact with the glucose sensing ion accelerators, electron bombardment ion thrusters or 
sides of the cones that are interrogated by light beams. If other electrostatic, electromagnetic or arc devices, to be 
shapes other than round, such as hemispheres, were used further described hereinafter. These different sources need to 
these shapes would allow a large area of contact between the be able to produce oxygen ion or atom energies of greater 
blood cells and the surfaces of the hemispheres. This large 50 than 1 eV. 
contact area may cause a misinterpretation of the glucose As known in the art, the resulting beams developed from 
level in the blood because of the light beam 20 interacting the source of greater than 1 eV are directed hyperthermal 
with the blood cells that lie on the surface. However, for beams. In one embodiment, the ends of thousand of optical 
conical surface structures, as provided by the present inven- fibers can be treated at one time. An arrangement 42 of the 
tion, negligible light reaches the very tip of the cones 36 and 55 apparatus for the desired processes is shown in FIG. 5, 
such interactions have little impact because of the micro- which is devoid, for the sake of clarity, of the desired 
scopic contact area therebetween. vacuum source, which will be further described hereinafter 
As known in the art, a diabetic patient wishing to measure with reference to FIG. 7. 
his or her blood glucose level would pierce the skin of a The arrangement 42 of FIG. 5 comprises a DC power 
finger with a lancet whose size and depth of penetration is 60 supply 44 having a preferred range of 25-150 volts, a 
designed to provide a minimally sized droplet, to be further cathode heater supply 46 connected to a cathode 48, and a 
described hereinafter, of blood at a minimized level of cooling supply 50 preferably being of water and connected 
associated pain. The patient would preferably then touch a to a water cooling coil 52 arranged with a water-cooled 
textured site 16 to the droplet, the fiber being advanta- radiation shield 54. 
geously pre-fixed to a measurement device. The patient 65 The arrangement 42 further comprises a hyperthermal 
would then read and record his or her blood glucose con- atomic oxygen source 56 that can be any source of oxygen 
centration determined upon wetout of the textured surface atoms or ions that produce a directed beam of energy greater 
than 1 eV and shown as beams 58, 60, or 62 and indicated The difision pump 86 receives heat from a heat supply 
as 0, O", 0," respectively. The ions in the beams 58,60, and 88 by way of elements 90 and 92. The diffusion pump 86 
62 can be single or multiply charged. The ionic or atomic also receives cooling (LNJ by means of a liquid nitrogen 
source 56 can be an End Hall source, an electron bombard- cooled trap 94. 
ment ion source, a DC plasma source, a microwave plasma 5 The apparatus of FIG. 7, using conventional elements, 
source or any other source provided the source delivers a provides for one method of the present invention that causes 
hyperthermal beam of greater than 1.0 V comprised of a solid light-conducting fiber used in the analyses of blood 
oxygen atoms or ions. and to have a desired textured surface 16 by first placing the 
The positive terminal of the DC power supply 44 is solid light-conducting fibers 10 or 12 having the distal end 
connected to an anode 66 of the source 56, whereas the 10 16 in a vacuum source 72 and then subjecting the distal end 
negative terminal of the DC power supply 44 is connected 16 to directed hyperthermal beams 58,60, or 62 comprising 
to the cathode 48. The directed hyperthenmil beams 58,60, oxygen atoms or ions. The operation of the apparatus of FIG. 
and 62 are preferably directed from one direction onto the 7 provides for textured surface 16, which may be further 
distal end 16 of each of the light-conducting fibers of the described with reference to FIG. 8. 
bundle 64, so as to produce the textured surface 16 thereon, 15 FIG. 8 shows a Scanning Electron Microscope image of 
which may be further described with reference to FIG. 6. an atomic oxygen textured polymethgylrnethaeralate optical 
FIG. 6 shows the textured surface as comprising the cones fiber that was textured by the practice of the present inven- 
28 that are separated from each other by distance no less tion using a hyperthermal (>1 eV) End Hall atomic or ionic 
than 1 micron and have an aspect ratio (lengthlwidth) that is oxygen source provided by the apparatus of FIG. 7. FIG. 8 
in the range of from about 1 to about 6. 20 shows that the separation between pillars and cones is 5 1 
The distance between the source 56 and the bundle 64 of micron and extremely thus suitable to prevent the cellular 
optical fiber can be varied from 3 cm to 200 cm provided the components of blood from entering the valleys between the 
atom or ion beam 58,60, and 62 does not become depleted cones or pillars 28 shown in FIG. 4. In addition, the aspect 
by scattering, in a manner known in the art, from back- ratio of the fibers is much greater than 1, far better than the 
ground oxygen gas molecules in a vacuum chamber, to be 25 aspect ratio of less than one (1) achieved by the thermal 
further described hereinafter with reference to FIG. 7. The energy atomic oxygen texturing shown in FIG. 1. 
thermal shield 54 is used to prevent sensitive optical fibers, One of the primary advantages of the present invention, 
such as those comprised in bundle 64, from melting. The relating to its minimally invasive feature, is the presence of 
shield 54 may be a water-cooled shield or may comprise a a large surface area in a very small, localized area, by which 
multi-layer insulation or even eliminated if the End Hall 30 a greatly increased level of analyte-responsive reagent can 
source 56 uses a hollow cathode 66 and does not produce be deposited and maintained. As more fully described in the 
much thermal radiation. For such an arrangement, the opti- previously incorporated by reference '937 patent, the large 
cal fibers do not need to be relatively close to the End Hall surface area disclosed in the '937 patent allows for the 
source 56, and if the optical fibers are farther away there is accommodation of blood samples preferably in the range of 
less cooling needed thereof. 35 l.O? to 2.5 microliters. Based on the practice of the present 
The bundle 64 is preferably brought together so as to invention, a ratio of 2 to about 6 increase in effective area 
provide a hexagonal close-packed array so that the directed relative to the teaching of the '937 patent is achieved which, 
atomic oxygen or ion beam 58,60, or 62 impinges on the end in turn, decreases the amount of blood sample required by a 
surface of all the fibers, that is the distal end 16 thereof, at factor of 2 to about 6. Thus, the practice of the present 
once so as to produce the textured surface 16 of all of the 40 invention accommodates a blood sample in the range from 
fibers making up the bundle 64. The atomic oxygen source about 0.5 to 1.25 microliters to about from 0.16 to about 
56 may cause heating of the optical bundle 64. To prevent 0.41. 
the heat sensitive polymers, such as polymethylmethacralate It should now be appreciated that the practice of the 
from melting, the water cooled or thermal-shield chill 54 is present invention provides for the use of directed hyperther- 
inserted between the End Hall cathode 66 and the optical 45 mal equal or greater than 1 eV beams comprising oxygen. 
fiber bundle 64, as shown in FIG. 5. atoms or ions to produce textured surfaces 16. The present 
In general, the length of the cones 28 and the spacing invention also provides for the thermal radiation shielding to 
between the cones 28, can be varied by simply changing the prevent overheating of the textured surfaces, while at the 
fluence (atomic and ionic oxygen exposure level). The same time, one embodiment uses an End Hall atomic or 
length and height have been found to grow in proportion to 50 ionic oxygen source, having a hollow cathode, and provid- 
the square root of the fluence (known in the art). The vacuum ing for texturing optical polymer surfaces without the use of 
source in which the bundle 64 of solid light-conducting thermal shielding. 
fibers are placed before being subjected to the hyperthermal The present invention makes use of the natural formation 
beams 58,60, or 62, may be further described with reference of cones or pillars that result in direct hypothennal (greater 
to FIG. 7. 55 than 1 eV) atomic or ionic oxidation of polymers. The 
FIG. 7 shows a vacuum source 72 having a door 74 apparatus of the present invention allows these cones or 
through which the bundle 64 of fibers may be entered. The pillars 28 to be sufficiently close or spaced so as to prevent 
vacuum source 72 can be any configuration that allows cellular blood components from interfering with optical 
evacuation down to a pressure of less than 1x1F5 torr sensing of blood glucose concentration. The present inven- 
during atomic oxygen operation. 60 tion also provides for small samples of blood to be used as 
The vacuum source 72 shows provisions of a roughing compared to the previous prior art sensors performing the 
pump 76 that provides an output to a blower pump 78 which, same task. 
in turn, provides an output source of air to valves 80 and 82, While the present invention has been described more 
all in a manner known in the art. The valve 80 directs its particularly in the context of glucose determinations and 
output into the vacuum source 72 by way of gate valve 84, 65 whole blood by diabetics, the invention may be utilized in 
whereas the valve 82 directs its output into a diffusion pump the determination of other analytes as well, or as even 
86 (also known in the art). simultaneous determination of two or more analytes. 
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While the preferred invention is presently contemplated mm, said separated cones being free of any material ther- 
that has been shown in the drawing as described herein, ebetween other than said light-conducting fiber. 
variations of preferred embodiments will be apparent to 2. The sensor according to claim 1, wherein said cones 
those skilled in the art and the invention should not be have a conical shape. 
construed as limited to the specific forms as shown and 5 3. The sensor according to claim 1, wherein said textured 
described herein, but rather set forth in the following claims. distal end comprises cones having a length to width ratio 
What I claimed is: which is greater than one. 
1. A sensor comprising a single solid light-conducting 4. The sensor according to claim 1, wherein an analyte- 
fiber having predetermined diameter and textured surface responsive reagent is deposited on said fiber at said textured 
site consisting of a textured distal end prepared by being 10 distal end. 
placed in a vacuum and then subjected to directed hyper- 5. The sensor according to claim 1, wherein said light- 
thermal beams comprising oxygen ions or atoms, said tex- conducting fiber is transparent and is of polymer material 
tured distal end comprising cones separated from each other except for silicone. 
by an amount which is about I micron and said predeter- 
mined diameter being in the range from about 1 mm to 2 * * * * *  
